Why the study?
Does captopril improve aortic reactivity in streptozotocin-diabetic rats?
Does captopril improve aortic reactivity in streptozotocin-diabetic rats?
Sub-chronic treatment with captopril dose-dependently prevents functional changes in vascular reactivity in a diabetic rat model.
Supports captopril in diabetic rat vasculopathy; hypothesis-generating for human endothelial trials.
Diabetes mellitus is a primary risk factor for cardiovascular disorders. Strategies that interrupt the renin-angiotensin system have been known to reduce cardiovascular disease. The present study was performed to investigate the effect of sub-chronic administration of captopril on the aortic reactivity of streptozotocin-diabetic rats. Streptozotocin-diabetic rats received captopril (30 and 50 mg/kg per day) for 2 months. Contractile responses to phenylephrine (PE) and relaxation responses to acetylcholine (ACh) and isosorbide dinitrate (ISD) were obtained from aortic rings. Concentration-response curves from captopril-treated diabetic rats to PE were attenuated compared with vehicle (Saline)-treated diabetic rats, especially at a dose of 50 mg/kg captopril. In addition, endothelium-dependent relaxation responses induced by ACh were significantly higher in captopril-treated diabetic rats compared with diabetic rats. The endothelium-independent relaxation responses for ISD were found not to be significantly different among the groups. Therefore, sub-chronic treatment of diabetic rats with captopril in a dose-dependent manner could prevent the functional changes in vascular reactivity in diabetic rats.
No takes yet. Share an insight, caveat, or question.
Baluchnejadmojarad et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: